EBV Latent Membrane Proteins (LMPs) 1 and 2 as Immunotherapeutic Targets: LMP-Specific CD4+ Cytotoxic T Cell Recognition of EBV-Transformed B Cell Lines1

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Journal of Immunology

• Publication date

  2008-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.4049/jimmunol.180.3.1643PMID 18209060
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• CD4 and CD8 T cell responses to tumour-associated Epstein–Barr virus antigens in nasopharyngeal carcinoma patients

  2008influential reference
• Cellular responses to viral infection in humans: lessons from Epstein-Barr virus.

  2007cited by this paper
• CD4+ T-Cell Responses to Epstein-Barr Virus (EBV) Latent-Cycle Antigens and the Recognition of EBV-Transformed Lymphoblastoid Cell Lines

  2005influential reference
• Treatment of nasopharyngeal carcinoma with Epstein-Barr virus--specific T lymphocytes.

  2005cited by this paper
• Endogenous human cytomegalovirus gB is presented efficiently by MHC class II molecules to CD4+ CTL

  2005cited by this paper
• Differential targeting and shifts in the immunodominance of Epstein-Barr virus--specific CD8 and CD4 T cell responses during acute and persistent infection.

  2005cited by this paper
• Epstein–Barr virus: 40 years on

  2004cited by this paper
• Towards a cellular definition of CD8+ T-cell memory: the role of CD4+ T-cell help in CD8+ T-cell responses.

  2004cited by this paper
• Cytotoxic T Lymphocyte Therapy for Epstein-Barr Virus+ Hodgkin's Disease

  2004cited by this paper
• Dual Stimulation of Epstein-Barr Virus (EBV)-Specific CD4+- and CD8+-T-Cell Responses by a Chimeric Antigen Construct: Potential Therapeutic Vaccine for EBV-Positive Nasopharyngeal Carcinoma

  2004cited by this paper
• Epstein‐Barr virus nuclear antigen 1 evades direct immune recognition by CD4+ T helper cells

  2004cited by this paper
• Major histocompatibility complex class II‐restricted presentation of a cytosolic antigen by autophagy

  2003cited by this paper
• Cytokine production and cytolytic mechanism of CD4(+) cytotoxic T lymphocytes in ex vivo expanded therapeutic Epstein-Barr virus-specific T-cell cultures.

  2002cited by this paper
• Characterization of CD4+ CTLs Ex Vivo1

  2002cited by this paper
• Treatment of Epstein-Barr-virus-positive post-transplantation lymphoproliferative disease with partly HLA-matched allogeneic cytotoxic T cells.

  2002cited by this paper
• Epstein-Barr Nuclear Antigen 1-Specific CD4+ Th1 Cells Kill Burkitt’s Lymphoma Cells1

  2002cited by this paper
• Induction of apoptosis by chemotherapeutic drugs: the role of FADD in activation of caspase-8 and synergy with death receptor ligands in ovarian carcinoma cells

  2002influential reference
• Antigen Presenting Cells Transfected with LMP2a RNA Induce CD4 + LMP2a-specific Cytotoxic T Lymphocytes which Kill via a Fas-independent Mechanism

  2002cited by this paper
• Inhibition of EBV-Induced Lymphoproliferation by CD4+ T Cells Specific for an MHC Class II Promiscuous Epitope1

  2002cited by this paper
• Processing of a Multiple Membrane Spanning Epstein-Barr Virus Protein for Cd8+T Cell Recognition Reveals a Proteasome-Dependent, Transporter Associated with Antigen Processing–Independent Pathway

  2001cited by this paper
• Differential Immunogenicity of Epstein-Barr Virus Latent-Cycle Proteins for Human CD4+ T-Helper 1 Responses

  2001cited by this paper
• Preferential utilization of the perforin/granzyme pathway for lysis of Epstein-Barr virus-transformed lymphoblastoid cells by virus-specific CD4+ T cells.

  2001cited by this paper
• Granule exocytosis, and not the fas/fas ligand system, is the main pathway of cytotoxicity mediated by alloantigen-specific CD4(+) as well as CD8(+) cytotoxic T lymphocytes in humans.

  2000cited by this paper
• The Importance of Exogenous Antigen in Priming the Human CD8+ T Cell Response: Lessons from the EBV Nuclear Antigen EBNA11

  2000cited by this paper
• Cytoplasmic Processing Is a Prerequisite for Presentation of an Endogenous Antigen by Major Histocompatibility Complex Class II Proteins

  2000cited by this paper
• Cloning genes encoding MHC class II-restricted antigens: mutated CDC27 as a tumor antigen.

  1999cited by this paper
• Fas-independent cytotoxicity mediated by human CD4+ CTL directed against herpes simplex virus-infected cells.

  1999cited by this paper
• Activation and adoptive transfer of Epstein-Barr virus-specific cytotoxic T cells in solid organ transplant patients with posttransplant lymphoproliferative disease.

  1999cited by this paper
• Rapid on/off cycling of cytokine production by virus-specific CD8+ T cells

  1999cited by this paper
• Functional subsets of CD4 T cells in rheumatoid synovitis.

  1998cited by this paper
• Infusion of cytotoxic T cells for the prevention and treatment of Epstein-Barr virus-induced lymphoma in allogeneic transplant recipients.

  1998cited by this paper
• Entry and trafficking of granzyme B in target cells during granzyme B-perforin-mediated apoptosis.

  1998cited by this paper
• CD4+ T cells inhibit growth of Epstein-Barr virus-transformed B cells through CD95-CD95 ligand-mediated apoptosis.

  1998cited by this paper
• Specific latent membrane protein 1 gene sequences in type 1 and type 2 Epstein‐Barr virus from nasopharyngeal carcinoma in Hong Kong

  1998cited by this paper
• Human CD8+ T cell responses to EBV EBNA1: HLA class I presentation of the (Gly-Ala)-containing protein requires exogenous processing.

  1997cited by this paper
• Conserved CTL epitopes within EBV latent membrane protein 2: a potential target for CTL-based tumor therapy.

  1997cited by this paper
• Class I processing-defective Burkitt's lymphoma cells are recognized efficiently by CD4+ EBV-specific CTLs.

  1997cited by this paper
• Human autoreactive CD4+ T cell clones use perforin- or Fas/Fas ligand-mediated pathways for target cell lysis.

  1997cited by this paper
• Transcription factors of the NFAT family: regulation and function.

  1997cited by this paper
• The Endogenous Pathway of MHC Class II Antigen Presentation

  1996cited by this paper
• The life span of major histocompatibility complex-peptide complexes influences the efficiency of presentation and immunogenicity of two class I-restricted cytotoxic T lymphocyte epitopes in the Epstein-Barr virus nuclear antigen 4

  1996cited by this paper
• Concanamycin A, a powerful tool for characterization and estimation of contribution of perforin- and Fas-based lytic pathways in cell-mediated cytotoxicity.

  1996cited by this paper
• Isolation of cytotoxic T lymphocytes from healthy seropositive individuals specific for peptide epitopes from Epstein-Barr virus nuclear antigen 1: implications for viral persistence and tumor surveillance.

  1995cited by this paper
• Studies of the mechanism of cytolysis by HIV-1-specific CD4+ human CTL clones induced by candidate AIDS vaccines.

  1994cited by this paper
• Localization of Epstein-Barr virus cytotoxic T cell epitopes using recombinant vaccinia: implications for vaccine development

  1992cited by this paper
• Identification of target antigens for the human cytotoxic T cell response to Epstein-Barr virus (EBV): implications for the immune control of EBV-positive malignancies

  1992cited by this paper
• MHC class II-restricted presentation of intracellular antigen.

  1991cited by this paper

• Expansion of a distinct cytotoxic CD4 TFH-cell cluster in lymph nodes of patients with complicated Common Variable Immunodeficiency.

  2025cites this paper
• Immune Evasion by Epstein-Barr Virus.

  2025cites this paper
• Research landmarks on the 60th anniversary of Epstein-Barr virus

  2024cites this paper
• Cytotoxic CD4+ T cells in chronic viral infections and cancer

  2023cites this paper
• Epstein-Barr virus infection: the micro and macro worlds

  2023cites this paper
• Aiolos represses CD4+ T cell cytotoxic programming via reciprocal regulation of TFH transcription factors and IL-2 sensitivity

  2023cites this paper
• mRNA-Based Vaccine Designing against Epstein-Barr Virus to Induce an Immune Response Using Immunoinformatic and Molecular Modelling Approaches

  2022cites this paper
• CD4+ Cytotoxic T cells - Phenotype, Function and Transcriptional Networks Controlling Their Differentiation Pathways.

  2022cites this paper
• Comprehensive Analysis of Epstein-Barr Virus LMP2A-Specific CD8+ and CD4+ T Cell Responses Restricted to Each HLA Class I and II Allotype Within an Individual

  2022cites this paper
• CD4+ Cytotoxic T Lymphocytes in Cancer Immunity and Immunotherapy

  2022cites this paper
• Vaccination as a therapeutic strategy for Nasopharyngeal carcinoma.

  2022cites this paper
• Immunoinformatics prediction of potential B-cell and T-cell epitopes as effective vaccine candidates for eliciting immunogenic responses against Epstein–Barr virus

  2021cites this paper
• Cytotoxic CD4+ T-cells specific for EBV capsid antigen BORF1 are maintained in long-term latently infected healthy donors

  2021cites this paper
• EBV Infection and Human Primary Immune Deficiencies

  2020influential citation
• Immunology of EBV-Related Lymphoproliferative Disease in HIV-Positive Individuals

  2020cites this paper
• The T-cell Response to Epstein-Barr Virus–New Tricks From an Old Dog

  2019cites this paper
• Primary EBV Infection Induces an Acute Wave of Activated Antigen-Specific Cytotoxic CD4+ T Cells

  2019cites this paper
• Identification of fatal outcome in a childhood nasopharyngeal carcinoma patient by protein expression profiling.

  2018cites this paper
• The Single-Cell Phenotypic Identity of Human CD8+ and CD4+ T Cells.

  2018cites this paper
• Cellular-based immunotherapy in Epstein-Barr virus induced nasopharyngeal cancer.

  2018cites this paper
• Fighting Viral Infections and Virus-Driven Tumors with Cytotoxic CD4+ T Cells

  2017cites this paper
• Cytotoxic CD4 T Cells—Friend or Foe during Viral Infection?

  2017cites this paper
• CD4 CTL, a Cytotoxic Subset of CD4+ T Cells, Their Differentiation and Function

  2017cites this paper
• IgG4-related disease

  2017cites this paper
• Assessment of combined vaccination and immune modulation as an anti-tumour therapy

  2016cites this paper
• PD-1/CTLA-4 Blockade Inhibits Epstein-Barr Virus-Induced Lymphoma Growth in a Cord Blood Humanized-Mouse Model

  2016cites this paper
• Cytotoxic CD4 T Cells: Differentiation, Function, and Application to Dengue Virus Infection

  2016cites this paper
• Association Between Response to Etrolizumab and Expression of Integrin αE and Granzyme A in Colon Biopsies of Patients With Ulcerative Colitis.

  2016cites this paper
• The Development of Prophylactic EBV Vaccines

  2016cites this paper
• The Use of Rabbit Model for the Efficacy of a Novel Epstein-Barr virus (EBV) Peptide Vaccine

  2016cites this paper
• Therapeutic vaccination strategies to treat nasopharyngeal carcinoma.

  2016cites this paper
• A revised strategy for monitoring BKV-specific cellular immunity in kidney transplant patients.

  2015cites this paper
• EBV Oncogene N-LMP1 Induces CD4 T Cell–Mediated Angiogenic Blockade in the Murine Tumor Model

  2015cites this paper
• The immunology of Epstein-Barr virus-induced disease.

  2015cites this paper
• Epstein Barr Virus Volume 2

  2015cites this paper
• Hypersensitivity to influenza vaccine in a case of Epstein–Barr virus‐associated T‐lymphoproliferative disorder

  2015cites this paper
• Errata

  2015cites this paper
• T cells specific for different latent and lytic viral proteins efficiently control Epstein-Barr virus-transformed B cells.

  2015cites this paper
• T-Cell Responses to EBV.

  2015cites this paper
• Murine Tumor Model Mediated Angiogenic Blockade in the -Oncogene N-LMP1 Induces CD4 T Cell

  2015cites this paper
• Nasopharyngeal Carcinoma: An Evolving Role for the Epstein-Barr Virus.

  2015cites this paper
• Combination of Epstein-Barr virus nuclear antigen 1, 3 and lytic antigen BZLF1 peptide pools allows fast and efficient stimulation of Epstein-Barr virus-specific T cells for adoptive immunotherapy.

  2014cites this paper
• Inflammation Enhances IL-2 Driven Differentiation of Cytolytic CD4 T Cells

  2014cites this paper
• Assessing the function of EBV-specific CD4\(^+\) T cells

  2014cites this paper
• Adenovirus-Based Vaccines against Rhesus Lymphocryptovirus EBNA-1 Induce Expansion of Specific CD8+ and CD4+ T Cells in Persistently Infected Rhesus Macaques

  2014cites this paper
• EBNA1-specific T cell responses during persistent rhesus LCV infection and the development of a novel therapeutic prototype vaccine for EBV-associated diseases

  2014cites this paper
• Immunobiology of Emerging Human DNA Viruses

  2014cites this paper
• CD4 CTL: living up to the challenge.

  2013influential citation
• 47 – Epstein-Barr virus vaccines

  2013cites this paper
• CD4 T Cell Responses in Latent and Chronic Viral Infections

  2013cites this paper
• Herpesviruses Placating the Unwilling Host: Manipulation of the MHC Class II Antigen Presentation Pathway

  2012cites this paper
• A profile of immune response to herpesvirus is associated with radiographic joint damage in rheumatoid arthritis

  2012cites this paper
• T cell immunity to Kaposi’s sarcoma-associated herpesvirus latent proteins

  2012cites this paper
• Immune defence against EBV and EBV-associated disease.

  2011cites this paper
• Investigating the role of Epstein-Barr virus in the pathogenesis of NK and T cell lymphoproliferations

  2011cites this paper
• Cytotoxic CD4+ T Cell Responses to EBV Contrast with CD8 Responses in Breadth of Lytic Cycle Antigen Choice and in Lytic Cycle Recognition

  2011cites this paper
• Infectious agents in human cancers: lessons in immunity and immunomodulation from gammaherpesviruses EBV and KSHV.

  2011cites this paper
• Cytotoxic CD4 T Cells in Antiviral Immunity

  2011influential citation
• Reversal of gastrointestinal carcinoma‐induced immunosuppression and induction of antitumoural immunity by a combination of cyclophosphamide and gene transfer of IL‐12

  2011cites this paper
• Identification of an HLA-DPB1*0501 Restricted Melan-A/MART-1 Epitope Recognized by CD4+ T Lymphocytes: Prevalence for Immunotherapy in Asian Populations

  2011cites this paper
• Cycle Recognition Lytic Cycle Antigen Choice and in Lytic Contrast with CD8 Responses in Breadth of T Cell Responses to EBV + Cytotoxic CD4

  2011cites this paper
• Immunotherapy for Epstein-Barr virus-associated malignancies.

  2010cites this paper
• Burkitt Lymphoma: Pathogenesis and Immune Evasion

  2010cites this paper
• Immunomonitoring technologies for the evaluation of Modified Vaccinia Virus Ankara expressing HIV-1 nef as a vaccine against AIDS

  2010cites this paper
• Isolation and Characterization of T cell receptor Genes for Immunotherapy of Epstein-Barr-virus-associated Malignancies

  2010cites this paper
• Diagnostic and Protective Aspects of Humoral Immune Responses to Epstein-Barr Virus Encoded Proteins in Nasopharyngeal Carcinoma

  2010cites this paper
• Role of CD4+ Cytotoxic T Lymphocytes in the Control of Viral Diseases and Cancer

  2010cites this paper
• A novel latent membrane 2 transcript expressed in Epstein-Barr virus-positive NK- and T-cell lymphoproliferative disease encodes a target for cellular immunotherapy.

  2010cites this paper
• Prospects of a novel vaccination strategy for human gamma-herpesviruses

  2010cites this paper
• Cytolytic CD4 cells: Direct mediators in infectious disease and malignancy.

  2010influential citation
• Six-transmembrane epithelial antigen of the prostate as an immunotherapeutic target for renal cell and bladder cancer.

  2010cites this paper
• Perforin level in CD4+ T cells from patients with systemic lupus erythematosus

  2010cites this paper
• Isolation and characterization of T cell receptor genes for immunotherapy of Epstein-Barr-virus-associated malignancies

  2010cites this paper
• Dissertation zur Erlangung des Doktorgrades der Fakultät für Chemie und Pharmazie der LudwigMaximiliansUniversität München Immunomonitoring technologies for the evaluation of Modified Vaccinia Virus Ankara expressing HIV1 nef as a vaccine against AIDS

  2010cites this paper
• Nucleofection of DCs to generate Multivirus-specific T cells for prevention or treatment of viral infections in the immunocompromised host.

  2009cites this paper
• Vaccination against Her2/neu - expressing cancer using chimeric virus-like particles

  2009cites this paper
• Immunotherapy of Epstein-Barr Virus Associated Malignancies Using Mycobacterial HSP70 and LMP2A356–364 Epitope Fusion Protein

  2009cites this paper
• The impact of intercurrent EBV infection on ATP levels in CD4+ T cells of pediatric kidney transplant recipients

  2009cites this paper
• Cytotoxic human CD4(+) T cells.

  2008cites this paper
• Peptide epitope identification for tumor-reactive CD4 T cells.

  2008cites this paper
• Novel virally targeted therapies of EBV-associated tumors.

  2008cites this paper
• Cytotoxic human CD4(+) T cells.

  2008cites this paper